Medical Oncologist
Paying for testing
Indian and lower-cost alternatives to Oncotype DX
Several genomic recurrence tests developed in India cost a fraction of the international ones and aim to answer the same question. What differs is how much published evidence stands behind each. This page gives you the four things to establish before agreeing to any of them, and explains why the test name matters more than where it was made.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
Is there an Indian alternative to Oncotype DX?
Yes. Several genomic recurrence tests have been developed in India and cost a fraction of the international ones. They aim to answer the same question: how much chemotherapy would add on top of hormone tablets. What differs is how much evidence stands behind each of them.
Why a local test exists at all
The international tests are expensive, are rarely covered here and require tissue to be shipped abroad. For most Indian families that puts them out of reach entirely. A validated local test at a lower price changes who can have the question answered at all.
The question that actually matters
Not where the test was developed, but what evidence supports it and whether your oncologist will act on the result. A well-validated Indian test your oncologist trusts is worth more than an international one they would override.
Ask for the name of the specific test being proposed, and write it down. There is more than one.The vocabulary
Words that decide whether a test is trustworthy
- Validated
- Tested in a properly designed study against real outcomes and shown to predict what it claims. This is the single most important word.
- Prospective validation
- The strongest kind, where patients were enrolled and followed forward. It takes years, which is why fewer tests have it.
- Retrospective validation
- Tested against stored samples from patients already followed up. Useful and much quicker, though weaker than prospective evidence.
- Indian cohort
- Validated in Indian patients specifically. Worth asking about, since the age profile of breast cancer here differs from the West.
- Turnaround time
- How long the result takes. Local tests are usually faster, which matters when treatment is waiting.
- Peer reviewed
- The validation study was published in a journal and assessed by other scientists, rather than appearing only in company material.
How to judge one
Four things to establish before you agree
These apply to any test, Indian or international. Price is the last of them, not the first.
What evidence stands behind it
Ask whether the validation study was published and peer reviewed, how many patients it followed and for how long. A test with only company material behind it is not the same thing.
Whether it fits your situation
Validated in node-negative disease only, or also with nodes involved? Validated before menopause as well as after? These distinctions decide whether the result applies to you.
Match the test to your own report.Whether your oncologist will act on it
The question that settles everything. If they would not change their recommendation on a low result, the test is not worth its cost regardless of who made it.
What the all-in price is
Ask whether the quote includes handling, the hospital's charge and taxes. Then compare like with like against the international option rather than laboratory price against all-in price.
Get in writing
- The test name
- The all-in price
- The expected result date
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Side by side
Local and international tests, compared honestly
India-developed tests
International tests
Considerably cheaper, often by a large multiple
Expensive, and rarely covered by any scheme here
Run locally, so results usually come back faster
Tissue often shipped abroad, adding weeks
Some validated in Indian patients specifically
Validated mainly in Western populations
Length of follow-up behind them is generally shorter
Many years of follow-up in very large groups
Familiarity varies a great deal between oncologists
Widely recognised and cited in international guidelines
Being straight with you
What this page cannot tell you
It cannot tell you which test to have, and it deliberately does not rank them by name. The evidence behind each one changes as new studies are published, and a page that named a winner would be out of date within a year.
Cheaper is not automatically a compromise
Some Indian tests have been through proper published validation and are used routinely by oncologists here. Dismissing them because they cost less is as lazy as choosing them only because they cost less.
Nor is it automatically equivalent
Others have far less behind them. The gap between the best and the weakest locally developed test is wider than the gap between the international ones. This is exactly why the test name matters and why you should write it down.
What to do with all this
Ask for the name of the test, ask what published evidence supports it in patients like you, and ask whether your oncologist would act on a low result. If those three answers are solid, price becomes a reasonable basis for the final choice. If they are not, no price is low enough.
If the cost is the real obstacle
Say so directly. Many families spend weeks researching tests when the honest conversation is that the international one is out of reach. Your oncologist can tell you whether a validated local test is reasonable for your case, or whether the decision can be made on your grade, size and node result without any test at all. Both are respectable answers and neither costs you anything to ask for.
Commonly believed
What families assume about local tests
Anything developed in India must be second-rate.
Some of these tests have been validated in published studies and are used by oncologists who could order the international ones instead. Judge the specific test by its evidence, not by where the laboratory happens to be.
If it is cheaper, it must be the same test made locally.
It is not. These are different tests reading different genes, built by different groups. The price gap comes from where the work is done and what it is patented under, not from a copy being made of somebody else's method.
My oncologist should know every test on the market.
New tests appear regularly and no oncologist follows all of them. If you have been sent information about one, show it to them and ask what they make of the evidence. That is a reasonable request, not a challenge.
Any test is better than no test.
A poorly validated result that nobody will act on is worse than no result, because it sits in your file creating doubt for years. If your oncologist would not change their advice on it, keep the money.
Questions we are asked
Common questions about lower-cost genomic tests
Are Indian genomic tests reliable?
Some are, and are used routinely by oncologists here. Others have much less published evidence. The answer depends entirely on which test is being proposed, which is why you should ask for its name and what study supports it.
Will my oncologist accept the result?
Ask before you pay. If they would not change their recommendation on a low result from that particular test, the money buys nothing. This single question saves families more than any price comparison.
Is the result available faster?
Usually, because the tissue is not shipped abroad and there are no customs steps. That matters when you are waiting to start treatment, and it is a legitimate reason to prefer a local test where the evidence is adequate.
Does insurance cover the Indian tests?
Usually not, for the same reason as the international ones: most policies treat genomic testing as an investigation. The lower price is what makes them affordable, rather than any difference in coverage.
Can I have an Indian test if my nodes were positive?
Only if that test has been validated with nodes involved. Not all have. Ask specifically whether the validation covered node-positive patients, because applying a node-negative test to your situation is a real error.
Should I run both a local and an international test?
No. They read different genes and can disagree, leaving you with two numbers and no way to choose. Pick one with your oncologist, agree in advance that you will act on it, and stop there.
How do I check the evidence myself?
Ask for the name of the published validation study and the journal. A test with real evidence has a paper anyone can look up. If all you are offered is a brochure, that is your answer.
What if my hospital only offers one option?
That is common and not a problem in itself, so long as the test is validated for your situation. Ask whether they can arrange an alternative if you prefer, and what it would cost all in before deciding.
What moves the figure
What affects the cost
Four things change the total more than anything else.
The technique used
A shaped or image-guided delivery costs more than a conventional one, and is chosen on clinical grounds rather than preference.
How many sessions
The total is driven by the number of sittings or cycles, not by a single per-visit figure.
Supporting tests
Scans, blood work and pathology done alongside treatment are billed separately.
Your cover
Aarogyasri, CGHS, ECHS, EHS or cashless insurance usually change the out-of-pocket figure substantially.
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — Breast cancer gene expression tests
- Indian Council of Medical Research — ICMR
- Cancer Research UK — Tests to help decide on chemotherapy
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.